Sub-10 nm Cu5FeS4 cube for magnetic resonance imaging-guided photothermal therapy of cancer
Authors Wang D, Zhang Y, Guo Q
Received 21 July 2018
Accepted for publication 23 September 2018
Published 26 November 2018 Volume 2018:13 Pages 7987—7996
Checked for plagiarism Yes
Review by Single anonymous peer review
Peer reviewer comments 2
Editor who approved publication: Dr Linlin Sun
Dan Wang,1 Yuwen Zhang,1 Qi Guo2
1Department of Pathology, The First People’s Hospital of Shangqiu, Shangqiu, Henan 476000, China; 2Department of Orthopedics, The First People’s Hospital of Shangqiu, Shangqiu, Henan 476000, China
Background: Facile synthesis and small size theranostic agents have shown great potential for cancer diagnosis and treatment.
Purpose: A ternary compound (Cu5FeS4), Fe doped copper sulfide, with novel magnetic properties and strong near-infrared absorption was prepared for magnetic resonance imaging (MRI) imaging guided photothermal therapy of cancer.
Patients and methods: Firstly, the capability of magnetic resonance imaging based on the novel magnetic properties and the photothermal performance due to the strong near-infrared absorption was investigated in vitro. Then, the magnetic resonance imaging guided photothermal therapy for 4T1 tumor-bearing mouse was carried out.
Results: The Cu5FeS4 cube with good T1-weighted MRI, excellent photothermal performance and low cytotoxicity has been investigated. More importantly, the T1-weighted MRI for 4T1 tumor-bearing mouse will get the best contrast effect at tumor site after 8 h of intravenous injection of Cu5FeS4 cube. Under the guidance of the T1-weighted MRI, the PTT was carried out at 8 h after intravenous injection of Cu5FeS4 cube and only the group combined intravenous administration of Cu5FeS4 cube and laser irradiation nearly cured the tumor after 14 days.
Conclusion: Our study not only provides a new material for personalized treatment of tumors, but also further promotes potential applications of the cancer theranostic agents.
Keywords: magnetic nanoparticle, imaging, theranostic, 4T1, ultra-small
This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution - Non Commercial (unported, v3.0) License. By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms.Download Article [PDF] View Full Text [HTML][Machine readable]